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ABSTRACT: To obtain a molecular probe for specific protein detection, we have synthesized fluorogenic probe library of vast 
diversity on bacteriophage T7 via the gp10 based-thioetherificaion (10BASEd-T). A remarkable color-changing and turning-on probe 
was selected from the library, and its physicochemical properties upon target-specific binding were obtained.  Combination analyses 
of fluorescence emission titration, isothermal titration calorimetry (ITC), and quantitative saturation-transfer difference (STD) NMR 
measurements followed by in silico docking simulation, rationalized most plausible geometry of the ligand-protein interaction.
Rapid and readily-interpretable detection of a specific protein 
is crucial for broad range of disciplines, such as disease diag-
nostics1-3 and environmental/cellular monitoring.3-5 For this 
purpose, microenvironmentally-sensitive fluorogenic probes3, 6 
are frequently utilized. In particular, those that result in a color-
changing and turning-on (CCTO) (i.e. shift in the emission 
spectrum with an increase in light intensity on target recogni-
tion) are desirable because of the ease of implementation for 
practical use and the readily-interpretable readout.7 Among 
such probes, Prodan is one of the most predominantly-used 
fluorophores because of its remarkable CCTO property to re-
port on the microenvironment together with its relatively small 
size.8  
The mainstream approach for creating a target-protein detec-
tion probe using Prodan is to conjugate the fluorophore within 
a certain position of already-known ligands such as peptides.9, 
10 For instance, Imperiali et al. introduce Prodan at the penulti-
mate position of the C-terminus of ribonuclease S-binding pep-
tide, and successfully detect Pro-S protein by a fluorescence 
readout upon binding.11 Nevertheless, the introduction of the 
fluorogenic probe often results in the loss or weakens the target-
binding ability of the unmodified ligand. Ambiguous CCTO10, 
12 is another problem for the practical use, probably because ge-
ometry of Prodan on binding is not optimized and inappropriate. 
Moreover, these ‘rationally-designed’ probe development strat-
egies are usually limited to well-known pairs of host proteins 
and guest ligands. A more general strategy for creating a CCTO 
probe is required to enable fluorogenic detection of a broad 
range of target proteins. 
Meanwhile, we have recently reported on a method to create 
a modified-phage library through conjugation of artificial-mol-
ecule cores at designated cysteines in the randomized peptide 
region on a capsid protein (gp10) of T7 phage.13, 14 This gp10 
based-thioetherificaion (10BASEd-T) is carried out in a one-pot 
reaction without side reactions or loss of phage infectivity. Con-
sequently, the cores can co-evolve during selection for target 
specific binders with the phage display technology. By using 
the 10BASEd-T, here we conjugated Prodan with randomized 
peptide, to create a fluorogenic library with vast diversity (i.e. 
109), and successfully found a target-specific probe with re-
markable CCTO ability. 
Figure 1. (A) Structure of fluorogenic synthon (Badan; a precursor of 
Prodan). (B) Construction of a fluorogenic library through the 10BASEd-T. 
X represents randomized amino acid. 
 Starting form a commercially-available Prodan synthon (6-
bromoacetyl-2-dimethylaminonaphthalene; also referred as Ba-
dan), the 10BASEd-T was instantly performed as shown in Fig. 
1 (for the details, see SI). In advance to performing selection  
using the library, we used T7 phage displaying  a model peptide 
(-GSRVSCGGRDRPGCLSV),13 and confirmed the appropriate 
thioetherification of Badan. After the 10BASEd-T against the 
model phage, total proteins were subjected to sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis followed by fluores-
cence imaging. A single fluorescent band could be seen at the 
appropriate molecular weight (~40 kDa) of the peptide-fused 
gp10 (Fig. S1, SI). This indicated that the Prodan moiety was 
site-specifically conjugated with the designated Cys in the 
model T7 phage-displayed peptide; no other T7 phage coat pro-
teins including those required for infection was not alkylated.  
As a target protein for the proof-of-concept study, we chose 
glutathione S-transferase (GST) because in our previous work 
we have already evolved tetramethylrhodamine (TMR) to GST-
specific binders via the 10BASEd-T13. Thus a direct comparison 
between the TMR- and Prodan-evolvers could be made. Prior 
to biopanning, Badan was reacted with T7 phage-displayed 
peptide library (-SGGG-X3-C-X5-7-C-X3; where X represents 
any amino acids)13, 15, which had been generated from a vector 
of mid-copy-number expression (5-15 peptide molecules per a 
phage; T7Select10), via the 10BASEd-T as previously shown in 
Fig. 1B. To include the possibility that a doubly-alkylated pep-
tide may improve the affinity toward the target protein, we con-
jugated two Prodan cores into the library peptide with two cys-
teines.13 After the thioetherification, we examined the infectiv-
ity of the modified T7 phage library by plaque assay, and con-
firmed that the infectivity titre was fully retained (Fig. S2, SI).  
Five rounds of biopanning were performed against biotin-
lylated-GST, and enrichment of GST binders was assessed by 
enzyme-linked immunosorbent assay (ELISA). During the bi-
opanning, increasing stringent conditions such as shortening the 
binding time and increasing the washing frequency were ap-
plied stepwise to each round. After the panning, the Prodan-
conjugated polyclones on T7 phage showed the strongest bind-
ing to GST, whereas ones lacking the Prodan core structure did 
not (Fig. 2A). This suggests that the Prodan moiety played a 
crucial role in the peptide interaction with the target. Among 16 
randomly chosen single T7 phage plaques, 15 clones had posi-
tive signals with 12 of them showing strongest binding on 
ELISA. The clones gave consensus displaying-peptide se-
quences which are categorized in three different groups: 
NXVSC*XGZ (1), NPC*XXZ (2), and PGPC*G (3) (C* and Z 
Figure 2. Biopanning against glutathione S-transferase (GST) using the fluorogenic library (-SGGG-X3-C*-X5-7-C*-X3; Cys are conjugated with Prodan). (A) T7 
phage polyclones after each round (R) of biopanning were reacted with Badan. Both the modified and unmodified T7 phage polyclones were subjected to 
enzyme-linked immunosorbent assay (ELISA). Mixture of streptavidin and bovine serum albumin (BSA) served as mock proteins. (B) Sequence alignment of 
GST-binding 12 monoclones with strong ELISA signals. Cysteine is alkylated with the fluorogenic core (i.e. Prodan). Z and X represent hydrophobic and any 
amino acids, respectively. T7 phage monoclones were chosen from the phage pool after 5 rounds of biopanning, and then subjected to DNA sequencing. They 
are categorized in three groups, and consensus sequences within each group were highlighted in red. Consensus sequences between the groups were colored 
in yellow and orange, respectively.  
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Figure 3. (A) Fluorescence emission titration upon GST-binding by using the best CCTO probe (NTVSC*HGF; 1). (B) Determination of GST-
binding affinity (dissociation constant; KD) of the CCTO probe by relative fluorescence intensity change at 551 nm.  
 represent Prodan-conjugated Cys and hydrophobic amino acids, 
respectively; Fig. 2B).  These peptide sequences of Prodan-
evolvers were completely different from that of TMR-evolved 
ones (i.e. ZC*XZDGZ; C* represents TMR-conjugated Cys),13 
except for the C-terminal GZ. 
Next, we chemically synthesized peptides representing these 
three groups, and their specific-binding property was investi-
gated by fluorescence titration experiment against GST. All of 
the Prodan evolvers (1 – 3) possessed solvatochromic fluores-
cence property as we expected. A remarkable CCTO from weak 
yellow to bright cyan was observed when NTVSC*HGF (1) was 
titrated against GST (Fig. 3A), whereas moderate CCTO could 
be seen for 2 and 3 (Fig. S3, SI). The GST binding ability of the 
best Prodan-evolver (1) was almost equal to that of the previ-
ously discovered TMR-evolved one;13 the dissociation constant 
(KD) of 1 was estimated to be 5.2 ± 0.4 μM (Fig. 3B), which is 
almost identical that obtained independently by isothermal ti-
tration calorimetry (ITC) measurement (i.e. 2.4 ± 0.1 μM; Fig. 
S4A, SI). In contrast to the GST-specific binding of Prodan-
peptide conjugate (1), the surrounding peptide alone or Prodan 
core itself did not bind to GST (Fig. S4B and S4C, SI). Speci-
ficity of this probe was confirmed since 1 did not bind to a va-
riety of different target-unrelated proteins (Fig. 3B and S5, SI). 
These results suggested that both structures of the fluorogenic 
core and the rest of the surrounding peptide were essential for 
the GST-specific binding. Thermodynamic parameters were 
also obtained from ITC,14 and favorable enthalpy and entropy 
changes (ΔH and ΔS) were observed. These suggest that hydro-
gen bonding and van der Waals force, as well as hydrophobic 
effect, moderately contributed to the interaction between the 
Prodan-evolver 1 and GST. 
Glutathione (GSH) is a well-known GST-binding small lig-
and.16 We examined whether the Prodan-evolver 1 competes 
with GSH for the GST-binding. Interaction between 1 and GST 
was disrupted in the presence of GSH in a concentration-de-
pendent manner, and the bright cyan fluorescence turned back 
to the weak yellow upon competition (Fig. S6, SI). This strongly 
suggested that 1 binds to the GSH-binding pocket of GST, in a 
similar manner of rationally-designed Prodan-conjugated-GSH 
which shows ambiguous CCTO.10  
To obtain further insight of the site-specific binding of 
NTVSC*HGF (1) to GST, nuclear magnetic resonance (NMR) 
experiments were performed.  First, 1H-1H COSY experiment 
was carried out, and we found that aromatic- and / -carbon-
attached proton signals of the Prodan core and phenylalanine 
were broadened, and methyl protons of valine slightly shifted 
upon binding (Fig. S7, SI). This indicated that these hydropho-
bic moieties are important for the binding. Second, ligand-based 
epitope mapping was performed by saturation transfer differ-
ence (STD) NMR. To make it more quantitative, saturation time 
was varied in each measurement, and the relative STD intensi-
ties of these protons-of-interest were plotted against the satura-
tion time (Fig. S8, SI).17 Exponential curve fitting of the plot 
gave us relative saturation rate constant of each proton (k), 
which indicated the importance of these atoms upon binding. 
As summarized in Fig. 4, valine and the Prodan core strongly 
interacted with GST, whereas phenylalanine and histidine mod-
erately and weakly, respectively. The importance of the above 
residues in this CCTO interaction with GST was also supported 
by the observation that the amino acids at the 3rd and 5th posi-
tions from the N-terminus were always valine and cysteine-
Prodan (underlined), respectively, whereas the 6th histidine and 
8th phenylalanine were variable (italicized) within the consen-
sus sequence of NXVSC*XGZ discovered through 5-rounds of 
biopanning (Fig. 2B, group 1). 
To rationalize the binding geometry, we performed a protein-
ligand docking simulation using AutoDock.18, 19 Among the 
nine different geometries generated in a grid around the GSH-
binding pocket, only the best model with a lowest binding en-
ergy (Fig. S9, SI) was consistent with the STD-NMR results. 
The simulation suggested that the Prodan core plays a dominant 
role for the binding; it was buried inside the deep hydrophobic 
pocket and shielded from aqueous environment, which could 
have caused the remarkable CCTO observed. 
In conclusion, we demonstrated creation of a fluorogenic li-
brary with vast diversity in T7 phage, and successfully found 
GST-specific CCTO probes. In pioneering works of fluorogenic 
sensing without color-change, Winter et al.20 and Ito et al.21, 22 
elegantly selected nitrobenzoxadiazole (NBD)-conjugated anti-
bodies and peptides, respectively, from random library pools.  
Nevertheless, in most cases, selected target-specific binders do 
not increase fluorescence intensity upon target recognition and 
are not turning-on probe molecules.20, 22 Such inability may be 
because the position of the NBD may not be completely opti-
mized, resulting in fluorescence quenching via electron transfer 
from NBD to aromatic amino acid(s) within the hydrophobic 
pocket of the target protein.23 In contrast, Prodan-based probes 
could yield a remarkable color-change regardless of fluores-
cence-intensity change, enhancing the possibility of obtaining 
practical indicators with an unambiguous readout. We envision 
that a similar approach to that described here will create CCTO 
probes for many protein targets since Prodan, one of the small-
est probes possessing a neutral charge, can be buried into dif-
ferent hydrophobic pockets of these targets. We are now trying 
to confirm the generality/limitation of this probe-discovery sys-
tem by changing target proteins and/or derivatizations of the 
CCTO core structures. 
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Figure 4. Quantitative epitope mapping of the Prodan-evolver 
NTVSC*HGF (1) upon GST binding on the basis of STD-NMR measure-
ment. Relative saturation rate constant of each proton (k; shown here) 
was obtained from relative STD signal intensity (STD) at each saturation 
time (t) and maximum STD signal intensity (STDmax) by using an equa-
tion of STD = STDmax X (1-ekt) shown in Fig. S9. 
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